1\. Fleming I, Cooper J, Henson D, et al. American Joint Committee
on Cancer. AJCC cancer staging manual. 5. Lippincott-Raven,
Philadelphia; 1997.  
2\. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors,
fifth edition (1997). Union Internationale Contre le Cancer
and the American Joint Committee on Cancer. Cancer. Nov 1
1997;80(9):1803-1804.  
3\. Ho J. Stage classification of nasopharyngeal carcinoma: a review.
IARC scientific publications. 1977(20):99-113.  
4\. Lee AW, Foo W, Law SC, et al. Staging of nasopharyngeal carci-
noma: from Ho's to the new UICC system. Int J Cancer. Apr 20
1999;84(2):179-187.  
5\. Greene FL. AJCC cancer staging manual. Vol 1: Springer Science
& Business Media; 2002.  
6\. Sobin LH WC. TNM classification of malignant tumours.
International Union Against Cancer (UICC): 6th edition. New York:
Wiley-Liss; 2002. 2002.  
7\. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A.
AJCC cancer staging manual. Vol 649: Springer New York; 2010.  
8\. Sobin L, Gospodarowicz M, Wittekind C. TNM classification of
malignant tumors. Hoboken, NJ: Wiley-Blackwell; 2009.  
9\. Lee AW, Au JS, Teo PM, et al. Staging of nasopharyngeal carci-
noma: suggestions for improving the current UICC/AJCC Staging
System. Clinical oncology. Jun 2004;16(4):269-276.  
10\. Tang L, Li L, Mao Y, et al. Retropharyngeal lymph node metasta-
sis in nasopharyngeal carcinoma detected by magnetic resonance
imaging: prognostic value and staging categories. Cancer. Jul 15
2008;113(2):347-354.  
11\. Tang LL, Li WF, Chen L, et al. Prognostic value and staging cate-
gories of anatomic masticator space involvement in nasopharyngeal
carcinoma: a study of 924 cases with MR imaging. Radiology. Oct
2010;257(1):151-157.  
12\. Chen L, Liu L-Z, Chen M, et al. Prognostic value of subclassifica-
tion using MRI in the t4 classification nasopharyngeal carcinoma
intensity-modulated radiotherapy treatment. International Journal
of Radiation Oncology* Biology* Physics. 2012;84(1):196-202.  
13\. Luo DH, Yang J, Qiu HZ, et al. A new T classification based on
masticator space involvement in nasopharyngeal carcinoma: a
study of 742 cases with magnetic resonance imaging. BMC cancer.
2014;14(1):653.  
14\. Zhang GY, Huang Y, Cai XY, et al. Prognostic value of grad-
ing masticator space involvement in nasopharyngeal carcinoma
according to MR imaging findings. Radiology. Oct 2014;273(1):
136-143.  
15\. Sze H, Chan LL, Ng W, et al. Should all nasopharyngeal carcinoma
with masticator space involvement be staged as T4? Oral oncology.
2014;50(12):1188-1195.  
16\. Xiao Y, Pan J, Chen Y, et al. The prognosis of nasopharyngeal
carcinoma involving masticatory muscles: a retrospective analy-
sis for revising T subclassifications. Medicine (Baltimore). Jan
2015;94(4):e420.  
17\. Feng AC, Wu MC, Tsai SY, et al. Prevertebral muscle involvement
in nasopharyngeal carcinoma. International journal of radiation
oncology, biology, physics. Jul 15 2006;65(4):1026-1035.  
18\. Lee CC, Chu ST, Chou P, Lee CC, Chen LF. The prognostic influ-
ence of prevertebral space involvement in nasopharyngeal carci-
noma. Clin Otolaryngol. Oct 2008;33(5):442-449.  
19\. Zhou GQ, Mao YP, Chen L, et al. Prognostic value of preverte-
bral space involvement in nasopharyngeal carcinoma based on
intensity-modulated radiotherapy. International journal of radia-
tion oncology, biology, physics. Mar 1 2012;82(3):1090-1097.  
20\. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classifi-
cation for evaluation of neck metastatic adenopathy. AJR. American
journal of roentgenology. Mar 2000;174(3):837-844.  
21\. Ng WT, Lee AW, Kan WK, et al. N-staging by magnetic resonance
imaging for patients with nasopharyngeal carcinoma: pattern of
nodal involvement by radiological levels. Radiotherapy and oncol-
ogy : journal of the European Society for Therapeutic Radiology
and Oncology. Jan 2007;82(1):70-75.  
22\. Li W-F, Sun Y, Mao Y-P, et al. Proposed lymph node staging sys-
tem using the International Consensus Guidelines for lymph node
levels is predictive for nasopharyngeal carcinoma patients from
endemic areas treated with intensity modulated radiation therapy.
International Journal of Radiation Oncology* Biology* Physics.
2013;86(2):249-256.  
<!-- PageBreak -->  
<!-- PageNumber="111" -->
<!-- PageHeader="9 Nasopharynx" -->  
23\. Pan J XY, Qiu S, et al. A Comparison Between the Chinese 2008
and the 7th Edition AJCC Staging Systems for Nasopharyngeal
Carcinoma. American journal of clinical oncology. 2013;23:192-198.  
24\. Ou Yang PY, Su Z, Ma XH, Mao YP, Liu MZ, Xie FY. Comparison
of TNM staging systems for nasopharyngeal carcinoma,
and proposal of a new staging system. Br J Cancer. Dec 10
2013;109(12):2987-2997.  
25\. Yue D, Xu Y-F, Zhang F, et al. Is replacement of the supracla-
vicular fossa with the lower level classification based on mag-
netic resonance imaging beneficial in nasopharyngeal carcinoma?
Radiotherapy and Oncology. 2014;113(1):108-114.  
26\. Lee AW, Ng WT, Chan LK, et al. The strength/weakness of the
AJCC/UICC staging system (7th edition) for nasopharyngeal can-
cer and suggestions for future improvement. Oral oncology. Oct
2012;48(10):1007-1013.  
27\. Pan JJ, Ng WT, Zong JF, et al. Proposal for the 8th edition of the
AJCC/UICC staging system for nasopharyngeal cancer in the era of
intensity-modulated radiotherapy. Cancer. Nov 20 2015.  
28\. Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional
lymph node metastasis of nasopharyngeal carcinoma: a meta-
analysis of clinical evidence. BMC cancer. 2012;12(1):98.  
29\. Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyn-
geal carcinoma with PET/CT: comparison with conventional imag-
ing work-up. European journal of nuclear medicine and molecular
imaging. Jan 2009;36(1):12-22.  
30\. Lee S-w, Nam SY, Im KC, et al. Prediction of prognosis using
standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose
positron emission tomography for nasopharyngeal carcinomas.
Radiotherapy and Oncology. 2008;87(2):211-216.  
31\. Liu WS, Wu MF, Tseng HC, et al. The role of pretreatment FDG-
PET in nasopharyngeal carcinoma treated with intensity-modulated
radiotherapy. International journal of radiation oncology, biology,
physics. Feb 1 2012;82(2):561-566.  
32\. Kattan MW, Hess KR, Amin MB, et al. American Joint Committee
on Cancer acceptance criteria for inclusion of risk models for indi-
vidualized prognosis in the practice of precision medicine. CA: a
cancer journal for clinicians. Jan 19 2016.  
33\. Chan JKC PB, Kuo TT, Wenig BM, Lee AWM. Tumours of
the nasopharynx. In: Eveson BL, JW RP, Sidransky D, editors.
World Health Organization classification of tumour, pathology
and genetics. Head and neck tumours. Lyon: IARC Press ;. 2005:
815-897.  
<!-- PageNumber="9" -->
<!-- PageBreak -->  
<!-- PageBreak -->  
10